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Abstract
Background: The purpose of this study was to evaluate whether PFNA-II (Asia proximal femoral nail anti-rotation)
and DHS (dynamic hip screw) carry substantial post-operative hidden blood loss and to compare PFNA-II with DHS
in terms of post-operative hidden blood loss in elderly high-risk patients with intertrochanteric femur fractures(IFFs).
Methods: The clinical data from Jan 2005 to Apr 2015 of 186 patients with PFNA-II and 177 patients with DHS
were analyzed retrospectively. Indexes including pre- and post-operative blood routine, intra- and post-operative
blood loss and blood transfusion situation were analyzed. The situation of perioperative blood loss (visible and
hidden) was assessed.
Results: The intra-operative blood loss in the PFNA-II group was 34.7 ± 2.5 ml, the post-operative visible blood
loss was 54.7 ± 2.5 ml, and the hidden blood loss was 277.2 ± 7.6 ml. In the DHS group, the intra-operative blood
loss was 102.0 ± 7.0 ml, the post-operative visible blood loss was 78.8 ± 4.7 ml, and the hidden blood loss was
139.3 ± 9.6 ml. The intra-operative blood loss and the post-operative visible blood loss in the PFNA-II group were
significantly less than in the DHS group (p < 0.01). However, the post-operative hidden blood loss and the total
blood loss in the PFNA-II group were larger than in the DHS group (p < 0.01).
Conclusion: This study demonstrated that with PFNA-II and DHS, much post-operative hidden blood loss exists
in the treatment of intertrochanteric fractures in elderly high-risk patients and DHS is more favourable than PFNA-II in
terms of post-operative hidden blood loss.
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Background
With the rapid increase in the elderly population, intertro-
chanteric femur fractures(IFFs) have become a serious
health issue because they are common, morbid, costly and
associated with injury [1–3]. To remedy this, two effective
treatment methods, conservative treatment and surgical
intervention. There is a high rate of the complication of
prolonged immobilization, pneumonia, decubitus ulcers,
joint contractures, and thromboembolism in the conser-
vative treatment, which often contributes to high mortality
[4–7]. The increased incidence of shortening and intro-
versive deformity results in dysfunction. Hence, the
treatment is almost always surgical [8, 9]. The most
common options are either the dynamic hip screw
(DHS) or Asia proximal femoral nail anti-rotation (PFNA-
II) [10]. Current evidence-based clinical research, however,
has revealed that DHS may cause more intra- and post-
operative complications [8, 11–14]. PFNA-II can minimize
the risk of these implant-related complications and pro-
vide angular and rotational stability. This is especially im-
portant in osteoporotic bone and unstable IFFs of elderly
high-risk patients, allowing early mobilization and weight
bearing on the affected limbs [15–18]. The literature re-
ports that the biomechanical stability of PFNA-II is super-
ior to that of DHS [17, 19]. However, there is no definitive
conclusion thus far on which fixation method is optimal
for elderly high-risk patients with IFFs in reducing hidden
blood loss and improving prognosis.
Clinically, post-operative hidden blood loss is often ig-
nored in elderly high-risk patients, due to a relatively
simpler surgical procedure, shorter operative time and
less intra-operative visible blood loss [20]. Consequently,
critical patients are not dealt with in a timely manner or
experience other complications.
Recently, a large number of studies assessing blood loss
in the two fixed methods of IFFs have been performed
[21–23]. However, these studies have important limita-
tions in sample size, data processing, and methodology
quality and fail to draw a definitive conclusion on whether
PFNA-II or DHS result in substantial post-operative
hidden blood loss. Thus, to provide strong support for a
clinical decision, the clinical case data of 363 patients with
IFFs accepting the treatment with PFNA-II or DHS were
analyzed retrospectively to evaluate blood loss. Addition-
ally, we also propose some measures to reduce mortality.
Methods
General data
This study was reviewed and approved by the Medical
Ethical Committee (the First Affiliated Hospital, Sun
Yat-sen University), and an exemption from informed
consent was obtained from our responsible Investiga-
tional Ethical Review Board.
In this study, 1363 confirmed patients with an IFF
treated using the PFNA-II or DHS in our Department of
Orthopaedics, the First Affiliated Hospital of Sun Yat-sen
University, from January 2005 to April 2015, were enrolled
consecutively. There were 19 deaths among these patients
(7 deaths (0.5 %) due to pulmonary embolism within
30 days after surgery, 9 deaths (0.7 %) due to heart arrest
and 3 deaths (0.2 %) secondary to cerebral haemorrhage be-
fore surgery). The patient data were fully anonymized and
de-identified prior to access by the researchers. Our inclu-
sion criteria were as follows: ages ranging 65–95 years,
good cognitive function, IFFs (AO/OTA Type 3.1A1, 2, 3),
ability to walk independently without aids before fracture,
surgery performed on an average of 3 days (range, 1–6
days) after admission, and undergoing a DHS or PFNA-II
fixation (DHS: standard screw/blade; Synthes, West
Chester, PA, USA; PFNA-II: a solid titanium nail, 200/
240 mm in length, 11 or 12 mm in diameter, 125° or 130° in
collodiaphyseal angle (CCD), Smith & Nephew, Memphis,
Tennessee). Our exclusion criteria were as follows: patho-
logical fractures or the presence of metastatic disease, poly-
trauma, severe osteoarthritis, chemotherapy, the inability to
walk before injury, an American Society of Anaesthesiolo-
gists (ASA) score of V, hematologic diseases, laboratory
signs of bleeding disorders, diseases of erythrocyte injury,
consumption of non-steroidal anti-inflammatory drugs or
antithrombotic drugs, antiplatelet agents taken within one
month before surgery, chronic or acute liver diseases, organ
failure diseases, substantial blood loss (>1.0 L), deaths, infec-
tious diseases (e.g., acquired immune deficiency syndrome),
diabetes, hypertension, or mental illness (Table 1).
Based on these criteria, 922 patients were excluded. In
those patients, 105 patients were excluded because of the
use of antiplatelet drug (clopidogrel or aspirin). Another
228 patients refused to participate, leaving 441 patients eli-
gible for the study. During the follow-up, 73 patients re-
fused to continue participating in the study. Two patients
died from cardiac arrest, and 3 patients died of drowning,
cerebrovascular disease, and an automobile accident. Con-
sequently, 363 patients (375 primary operations, PFNA-II,
n = 186; DHS, n = 177) were involved in the final evaluation
(Table 2, Fig. 1). Osteoporosis was defined as bone mineral
density(BMD)T-score value ≤ −2.5 at the femoral neck.
Data collection
Recorded clinical data of patients included the following:
age, gender, body weight, height, and pre- and post-
operative routine blood parameters (hematocrit, HCT;
hemoglobin, Hb). The mean and SD of hemoglobin level
changes are shown in Table 3.
Intra-operative and post-operative treatment
Each patient was given a single dose of the antibiotic
teicoplanin (Aventis Pharma, Kings Hill, United Kingdom)
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30 min before surgery. The surgery was performed under
the direct supervision of senior surgeons. Patients were
operated on an extension table and positioned in the same
decubitus. Under general anaesthesia, each patient was
treated with a DHS or PFNA-II fixation device. All opera-
tions were performed in the same institution by experi-
enced orthopaedic surgeons (WY, YL, JY, YX, and JH).
The technique followed standard protocols and was iden-
tical to that described by Zhong et al. [8] for PFNA and
Jung et al. [9] for DHS. The length of incision in each
group is similar to recommended length (standard inci-
sions). The operation time lasted from the starting inci-
sion to the finishing suture of the incision. Intraoperative
blood loss was measured gravimetrically and added to the
blood loss measured in the suction bottles. The mass of
haemoglobin lost in suction was calculated as the product
of the suction volume and suction haemoglobin
concentration [Volsuction*HbConcsuction =HbMasssuction].
The total volume of blood lost in swabs was calculated as
the sum of the changes in weight of all swabs. The mass
of haemoglobin lost in swabs was calculated using the as-
sumption that the haemoglobin concentration in the
swabs would be similar to that of the suction [Volswabs
*HbConcsuction = HbMassswabs]. The wound drainage was
that obtained and measured from the wound suction
drain following surgery. Twenty-four hours later, the
drainage tube was removed according to the drainage
condition, and the total drainage of post-operation
(visible blood loss) was recorded. All patients had
their blood routine test performed at 7:00 AM of the
pre-operative day and on the second post-operative
day, and the appropriate treatment was carried out
according to the conditions of patients. Continuous
passive motion (CPM) was started on the 2nd-3rd
post-operative day.
Calculation method of hidden blood loss
Red blood cell amount, perioperative blood loss and hidden
blood loss were calculated using the Gross formula [24].
The details of the calculation method are as follows [25–27]:
Table 1 Major exclusion criteria
PFNA-IIb DHSc
Grand total 285 304
Hypertension (n) 51 45
Diabetes (n) 52 53
Hypertension and diabetes (n) 12 13
Rheumatoid arthritis (n) 8 12
Steroid consumption (n) 11 10
Kidney failure (n) 6 4
Hemodialysis (n) 5 11
Delirium and agitation (n) 2 1
Liver cirrhosis (n) 15 18
Organ transplant (n) 4 3
Oxygen dependence (n) 3 6
Hemodynamic instabilitya (n) 1 2
Concomitant use of heparin (n) 5 3
Multiple organ failure (n) 6 3
Heart failure (n) 3 9
Deaths (n) 12 7
Mental illness(n) 1 2
More blood loss (>1.0 L) (n) 2 6
Consumption of non-steroidal anti-
inflammatory drugs (n)
8 6
Diseases of erythrocyte injury (n) 5 1
Laboratory signs of bleeding disorders (n) 4 3
Hematologic diseases (n) 3 7
ASA score of V (n) 4 11
Inability to walk before injury (n) 5 8
Chemotherapy (n) 10 11
Poly-trauma (n) 13 22
Pathological fractures (n) 10 7
Multiple above mentioned indicators (n) 24 20
aRequirement for multiple pressors or inability to maintain mean arterial
pressure with single-pressor support. PFNA-II: Asia proximal femoral nail anti-
rotation; DHS dynamic hip screw. bSmith & Nephew, Memphis, Tennessee;
cSynthes, West Chester, PA, USA
Table 2 Patient details in this study
PFNA-IIb DHSc p-value
Gender Men Women Men Women
Total limbs (n) 194 181
81 113 80 101 0.632#
Total patients (n) 186 177
75 111 78 99 0.470#
Age range (y) 66–82 67–92 64–82 63–95 0.273#
Mean age (y) 76.4 79.6 74.6 80.3
Left side (n) 52 67 50 42 0.125#
Right side (n) 29 46 30 59 0.510#
BMD −3.73 ± 1.21 −3.98 ± 1.49 0.086#
Type of fracture 0.385#
Type-A1 fracture (n) 33 56 40 40
Type-A2 fracture (n) 24 24 18 38
Type-A3 fracture (n) 23 33 22 23
Length of hospital stay (d) 9.91 ± 3.47 10.40 ± 2.96 0.151#
Post-op HHSa 85.63 ± 4.13 82.59 ± 5.01 0.000*
Length of follow-up (mos) 39.58 ± 1.67 39.77 ± 1.41 0.234#
*Statistically significant values, #No statistically significant values, aAt
final follow-up
PFNA-II Asia proximal femoral nail anti-rotation-Asia; DHS dynamic hip screw;
HHS Harris hip score; BMD Bone mineral density. bSmith & Nephew, Memphis,
Tennessee; cSynthes, West Chester, PA, USA
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Patient’s total blood volume PBVð Þ in litersð Þ
¼ k1  h3 þ K2  w þ K3
where h = height in metres, and w = weight in kg
Men: K1 = 0.3669, K2 = 0.03219, K3 = 0.6041,
Women: K1 = 0.3561, K2 = 0.03308, K3 = 0.1833.
Total blood loss in litersð Þ ¼ PBV
 Hctpre−Hctpostð Þ
Hctave:
Hctpre: the initial pre-operative Hct,
Hctpost: the Hct for the second or third post-operative day,
Hctave: the average of Hctpre and Hctpost,
Fig. 1 Flow diagram demonstrating methods for identification of studies to assess the treatment of intertrochanteric femur fractures in the
elderly using either the Asia proximal femoral nail anti-rotation (PFNA-II) or the dynamic hip screw (DHS) systems, and reasons for exclusion
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Hidden blood loss ¼ calculated total blood loss
þ blood infused−measured blood loss:
Statistical analysis
All statistical analyses were performed using SPSS Statis-
tics version 22. All continuous data were expressed as
the mean ± standard deviation (SD). Quantitative vari-
ables were analyzed using Student’s t-test and categorical
variables were analyzed by the χ2 test or Fisher’s exact
test where appropriate. All tests were two-tailed. The
level of significance was set at p < 0.01 for all statistical
analyses.
Results
The details of the hidden and visible blood loss with
PFNA-II and DHS are shown in Table 4. Box plots show
the distribution characteristic of measured data (Fig. 2).
The frequency distribution of the total blood loss
measurements was that its concentration appeared as a
clearly centralized distribution in both groups: in Group
PFNA-II, most of the values are approximately 368 ml,
whereas in Group DHS, the values were approximately
320 ml (Fig. 3). As for hidden blood loss measurements,
the concentration also appeared as a clearly centralized
distribution in both groups: in Group PFNA-II, most of
the values were approximately 277 ml, in Group DHS,
approximately 139 ml (Fig. 4). A characteristics of the
statistical distribution of visible blood loss revealed that
in Group PFNA-II, most of the values were approxi-
mately 89 ml, whereas in Group DHS, the values were
approximately 180 ml (Fig. 5). Variable mean differences
between two groups are shown in Fig. 6. In Group
PFNA-II, the mean operation time was 35.5 ± 1.4 min.
The mean intra-operation blood loss was 34.7 ± 2.5 ml,
without blood transfusion during operation. Due to a
significant decrease in blood red protein (<8 g/L) on the
2nd-4th post-operative days, 36 patients were provided
with a blood transfusion, which averaged 300 ± 15 ml in
volume. The visible blood loss post-operation for 186
patients was an average of 89.4 ± 4.0 ml; the hidden
blood loss was an average of 277.2 ± 7.6 ml. There were
significant differences in the hidden blood loss, the post-
operative visible blood loss and the total blood loss be-
tween genders in Group PFNA-II (p < 0.01). The mean
follow-up period was 39 months (range, 37–42 months)
for two groups.
In Group DHS, the mean operation time was 51.1 ±
1.4 min. The intra-operation mean blood loss was 102.0
± 7.0 ml, with no intra-operative blood transfusion. Due
to a significant decrease in blood red protein (<8 g/L) on
the 2nd-4th postoperative days, 34 patients were pro-
vided with blood transfusions, which averaged 400 ±
10 ml in volume. The average visible blood loss and
hidden blood loss post-operation for 177 patients were
180.8 ± 9.0 ml and 139.3 ± 9.6 ml, respectively. There
were significant differences in the hidden blood loss, the





125.07 ± 1.60 123.40 ± 1.79 0.098#
Preoperative Hct (%) 32.64 ± 2.59 32.13 ± 2.59 0.837#
Postoperative hemoglobin
level (g/L)
103.59 ± 2.01 101.39 ± 2.31 0.016#
Postoperative Hct (%) 27.05 ± 0.53 25.92 ± 0.61 0.009*
Hemoglobin level loss (g/L) 21.47 ± 2.40 22.01 ± 2.98 0.001*
PT(s) 10.0 ± 0.6 10.0 ± 0.59 0.195#
APTT(s) 26.2 ± 1.7 26.0 ± 1.8 0.337#
INR 1.0 ± 0.1 1.0 ± 0.1 0.351#
*Statistically significant values, #No statistically significant values
PFNA-II Asia proximal femoral nail anti-rotation-Asia; DHS dynamic hip screw;
Hb hemoglobin; PT prothrombin time; APTT activated partial thromboplastin
time; INR international normalized ratio; Hct haematocrit. aSmith & Nephew,
Memphis, Tennessee; bSynthes, West Chester, PA, USA














Male 81 34.1 ± 1.2 33.0 ± 1.8 53.6 ± 2.1 272.9 ± 6.9 86.6 ± 2.6 359.5 ± 7.0
Female 105 36.5 ± 0.3* 36.0 ± 2.2* 55.6 ± 2.4* 280.5 ± 6.3* 91.6 ± 3.5* 372.1 ± 7.3*
Total 186 35.5 ± 1.4 34.7 ± 2.5 54.7 ± 2.5 277.2 ± 7.6 89.4 ± 4.0 366.6 ± 9.5
DHSb
Male 80 49.9 ± 0.6 100.0 ± 4.3 77.6 ± 3.9 133.0 ± 7.0 177.6 ± 5.6 310.5 ± 9.2
Female 97 52.1 ± 1.1* 103.7 ± 8.3* 79.7 ± 5.1* 144.6 ± 8.1* 183.5 ± 10.3* 328.1 ± 14.2*
Total 177 51.1 ± 1.4# 102.0 ± 7.0 # 78.8 ± 4.7# 139.3 ± 9.6# 180.8 ± 9.0# 320.1 ± 15.0#
PFNA-II Asia proximal femoral nail anti-rotation; DHS Dynamic hip screw. *p < 0.01, the male patients vs. the female patients in the same group; #p < 0.01 total pa-
tients in Group PFNA-II vs. total patients in Group DHS. Visible blood loss = Intra operation bleed + Post operation drainage. aSmith & Nephew, Memphis, Tennes-
see; bSynthes, West Chester, PA, USA
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Fig. 2 Box plots showing the characteristics of its statistical distribution. DHS, dynamic hip screw; PFNA-II, Asia proximal femoral nail anti-rotation
Fig. 3 Frequency distribution of the total blood loss measurements. Its concentration is shown as the obviously centralized distribution in two
groups, and in Group PFNA-II, most of the values are approximately 368 ml, in Group DHS, approximately 320 ml.DHS, dynamic hip screw; PFNA-II,
Asia-proximal femoral nail anti-rotation
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Fig. 4 Frequency distribution of the hidden blood loss measurements. Its Concentration is shown as the obviously centralized distribution in two
groups, and in Group PFNA-II, most of the values are approximately 277 ml, in Group DHS, approximately 139 ml. DHS, dynamic hip screw; PFNA-II, Asia
proximal femoral nail anti-rotation
Fig. 5 Frequency distribution of the visible blood loss measurements. Its concentration is shown as the obviously centralized distribution in two
groups, and in Group, most of the values are approximately 89 ml, in Group DHS, approximately 180 ml.DHS, dynamic hip screw; PFNA-II, Asia
proximal femoral nail anti-rotation
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post-operative visible blood loss and the total blood loss
between genders in Group DHS (p < 0.01).
The operation time was clearly shorter in Group
PFNA-II than in Group DHS. The intra-operative blood
loss and the post-operative visible blood loss in Group
DHS were significantly larger than those in Group
PFNA-II. Additionally, the hidden blood loss and total
post-operative blood loss were significantly larger than
those in Group DHS. There were significant differences
between the two groups in terms of the operation time
and the blood loss (p < 0.01).
Discussion
Intertrochanteric fractures are associated with significant
intra- and post-operative blood loss. When analyzing
total blood loss during orthopaedic surgery, the standard
is to measure intra-operative bleeding plus postoperative
drainage, which ignores hidden blood loss that has been
found to be significant in the field of surgery [25]. Add-
itionally, hidden blood loss is also often ignored in clin-
ical practice, due to simpler surgical procedures, shorter
operation time and less intra-operative visible blood loss.
Therefore, it is easy to aggravate the medical comorbidi-
ties or promote the occurrence of other complications.
In elderly high-risk patients, intertrochanteric fractures
are more often accompanied by a variety of other dis-
eases. The risk of surgery mainly comes from the med-
ical comorbidities of patients. Hence, the perioperative
assessment, the monitoring of vital signs and the neces-
sary measures will be especially important.
Our results are in accordance with the aforementioned
studies. In the two groups of patients accepting PFNA-II
or DHS treatment, the gender ratio, fracture typing and
distribution of complications were consistent and com-
parable. However, there was a difference in the mean age
between men and women in each group, with the mean
age of women being significantly higher than that of
men. Although the difference does not affect the con-
trast between the two groups, it may be the reason for
the index differences between men and women within
each group. Some post-operative patients in both groups
presented the symptoms of anaemia, such as feeble mus-
cles, mental fatigue, loss of appetite, haemoglobin de-
cline, etc. According to perioperative statistical data
analysis, we discovered that the intra-operative blood
loss and the post-operative visible blood loss were less
than the true total amount of blood loss. Therefore, it
was speculated that a large amount of hidden blood loss
exists. This study showed that the mean hidden blood
loss in patients undergoing PFNA-II treatment was
277.2 ± 7.6 ml, nearly 75 % of the total amount of blood
loss, whereas the mean volume of hidden blood loss in
patients treated with DHS was 139.3 ± 9.6 ml, approxi-
mately 44 % of the total amount of blood loss. We also
found that no matter the PFNA-II group or DHS group,
there were significant differences in the comparison of
the post-operative visible blood loss, the hidden blood
Fig. 6 Variable mean differences between two groups: in Group DHS, IOB and POD are larger than that in Group PFNA-II, HBL and TBL are less
than that in Group PFNA-II. DHS, dynamic hip screw; PFNA-II, Asia proximal femoral nail anti-rotation; IOB, Intra-operation bleed; POD, Post-operation
drainage; HBL, Hidden blood loss; TBL, Total blood loss
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loss and the total blood loss between men and women.
In an analysis of the reasons, there may be some differ-
ences in the age of men and women within each group.
Although the total number of male patients is relatively
close to that of female patients, the female patient age
was significantly higher, which may be related to the lon-
ger life expectancy of females compared to males. That
might make the female compensatory ability worse than
that of the male [26].
The causes and mechanism of hidden blood loss are
not yet clear. The intertrochanteric fracture belongs to
the fractures of the metaphysis, which are rich in blood
supply. When the intramedullary needle is fixed, the
process of expanding the medullary cavity could lead to
internal bleeding. In addition, the intramedullary cavities
and intramuscular gaps also provide storage cavities for
hidden blood loss. Foss, N.B. et al. [28] hypothesized
that hidden blood loss could originate from post-
operative haemorrhage, the gastrointestinal tract and the
initial trauma. Millar, Neal L. et al. [29] suspected intra-
medullary penetration was associated with hidden blood
loss. Jung et al. [9] argued that the main reason for hid-
den blood loss is the compression of the incision result-
ing from perioperative blood pouring into the tissue
compartments that are not involved in the systemic cir-
culation, resulting in a further reduction of haemoglobin
levels, which may be related to an abnormal capillary
bed opening caused by free fatty acids, intraoperative
intramedullary fat, bone cement and bone debris enter-
ing the blood circulation [30,31]. However, at present,
there is not yet sufficient evidence to support this infer-
ence. Therefore, it is clear that we should put great em-
phasis on the analysis of hidden blood loss,
individualized estimation of total perioperative blood
loss, perioperative monitoring, attention to changes in
vital signs and urine, control of blood glucose and blood
pressure, supplementation of blood levels, prevention of
deep-vein thrombosis, and active functional training of
the affected limb.
In the present study, the clinical blood loss of patients
accepting the treatment of DHS or PFNA-II was ana-
lyzed. The results showed that in Group PFNA-II, there
was less intra-operative blood loss and more post-
operative hidden blood loss. The intra-operative blood
loss in Group PFNA-II was less than that in Group
DHS. The post-operative hidden blood loss in Group
DHS was significantly less than that in Group PFNA-II.
According to the data analysis results and clinical
experience, PFNA-II is an intramedullary fixation, whose
damage to the intramedullary blood supply is of a
greater extent compared to DHS. Therefore, the post-
operative hidden blood loss of patients receiving treat-
ment with PFNA-II was significantly larger than that of
the DHS group. In this study, a post-operative blood
losses resulting from two commonly used clinical surgi-
cal treatment methods were compared. However, we
cannot conclude that the difference in the amount of
visible blood loss and hidden blood loss was necessarily
caused by the difference in the two kinds of surgical
methods, as there was still the existence of hidden
bleeding in patients receiving non-surgical treatment of
intertrochanteric fractures. Thus, if the reasons could be
analzsed to exclude this factor, we could draw conclu-
sions on visible and hidden blood loss resulting from
surgical factors. Because clinical intertrochanteric frac-
tures have mostly been treated with surgery in recent
years, it is more difficult to obtain the complete data of
patients with non-surgical treatment to compare the
amount of the hidden blood loss of patients with non-
surgical treatment with that of patients with surgical
treatment. In addition, because the Group DHS patient
cases were mostly completed before 2015, the distribu-
tion of the samples was not uniform, which was a limita-
tion of this study. Additionally, no gold standard has
been found to measure perioperative blood loss. As a
consequence, the evaluation had to be compared with
an established technique rather than against the actual
quantity. The assessment of the ‘true’ blood loss also
had limitations [27].
Conclusion
The research results fully demonstrated that much post-
operative hidden blood loss exists with PFNA-II and
DHS in the treatment of intertrochanteric fractures of
elderly high-risk patients, and DHS is more favorable than
PFNA-II in terms of post-operative hidden blood loss.
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